An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2

Tomoregulin Internalization Confers Selective Cytotoxicity of Immunotoxins on Prostate Cancer Cells

(2014) Xiao-Yan Zhao et al.   Translational Oncology

Compartmental Tissue Distribution of Antibody Therapeutics: Experimental Approaches and Interpretations

(2012) C. Andrew Boswell et al.   AAPS Journal

Differential Effects of Predosing on Tumor and Tissue Uptake of an 111In-Labeled Anti-TENB2 Antibody-Drug Conjugate

(2012) C. A. Boswell et al.   JOURNAL OF NUCLEAR MEDICINE

Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model

(2012) C. V. Pastuskovas et al.   MOLECULAR CANCER THERAPEUTICS

Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats

(2011) C. Andrew Boswell et al.   BIOCONJUGATE CHEMISTRY

Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancer

(2011) Howard A Burris   EXPERT OPINION ON BIOLOGICAL THERAPY

Brentuximab vedotin for the treatment of CD30+lymphomas

(2011) Kelley V Foyil et al.   Immunotherapy

Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow

(2011) C. Andrew Boswell et al.   PLoS One

Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics

(2010) C. Andrew Boswell et al.   BIOCONJUGATE CHEMISTRY

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Development and Evaluation of a Novel Method for Preclinical Measurement of Tissue Vascular Volume

(2010) C. Andrew Boswell et al.   MOLECULAR PHARMACEUTICS

Treatment strategies for high-risk locally advanced prostate cancer

(2010) Seth A. Rosenthal et al.   Nature Reviews Urology

Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal Antibodies

(2009) Laurent Ducry et al.   BIOCONJUGATE CHEMISTRY

Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma

(2009) D. Dornan et al.   BLOOD

Therapeutic antibodies: successes, limitations and hopes for the future

(2009) Patrick Chames et al.   BRITISH JOURNAL OF PHARMACOLOGY

Patient Decision Aids for Prostate Cancer Treatment: A Systematic Review of the Literature

(2009) G. A. Lin et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Antibody-Drug Conjugate Targets

(2009) B. Teicher   CURRENT CANCER DRUG TARGETS

Potent antibody drug conjugates for cancer therapy

(2009) Peter D Senter   CURRENT OPINION IN CHEMICAL BIOLOGY

The Pharmacologic Basis for Antibody-Auristatin Conjugate Activity

(2009) S. C. Alley et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates

(2009) B. Zheng et al.   MOLECULAR CANCER THERAPEUTICS

Innovations in the systemic therapy of prostate cancer

(2009) Dale R. Shepard et al.   Nature Reviews Clinical Oncology

Anti-CD22-MCC-DM1 and MC-MMAF Conjugates: Impact of Assay Format on Pharmacokinetic Parameters Determination

(2008) Jean-Philippe Stephan et al.   BIOCONJUGATE CHEMISTRY

Novel Peptide Linkers for Highly Potent Antibody−Auristatin Conjugate

(2008) Svetlana O. Doronina et al.   BIOCONJUGATE CHEMISTRY

Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates

(2008) Stephen C. Alley et al.   BIOCONJUGATE CHEMISTRY

Management of Complications of Prostate Cancer Treatment

(2008) M. D. Michaelson et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Antibody-Drug Conjugates for Cancer Therapy

(2008) Paul J. Carter et al.   CANCER JOURNAL

New horizons in prostate cancer imaging

(2008) Gregory Ravizzini et al.   EUROPEAN JOURNAL OF RADIOLOGY

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

(2008) Jagath R Junutula et al.   NATURE BIOTECHNOLOGY